CTRI/2024/02/062740尚未招募3 期
Tofacitinib for calcinosis cutis associated with juvenile dermatomyositis: an open label single arm study - TOFCA
Department of Pediatrics, AIIMS, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Children age 2 to 18 years with
- •-Juvenile Dermatomyositis (JDM) OR Juvenile Dermatomyositis Systemic Scleroderma overlap (JDM-SSc) AND
- •-calcinosis cutis on physical examination or previous imaging.
排除标准
- •1Patient cyclophosphamide during the preceding 1 month or rituximab in the last 6 months OR
- •-Topical tacrolimus OR
- •- Active Tuberculosis OR
- •- Hemoglobin (Hb) levels less than 9 g per dL OR
- •- Absolute lymphocyte count less than 500 cells per mm3
- •-Absolute neutrophil count less than 1000 cells per mm3
研究者
相似试验
已完成
2 期
Tofacitinib in the treatment of chronic, recurrent and/or antibiotic refractory pouchitis: a multi-omics approachinflammation of the pouch reservoir10017969PouchitisNL-OMON52963Academisch Medisch Centrum13
进行中（未招募）
1 期
Treatment of refractory pouchitis with tofacitinibEUCTR2020-002695-12-NLAmsterdam UMC, location AMC12
尚未招募
不适用
Treatment of chronic, recurrent and/or antibiotic refractory pouchitis with tofacitinibNL-OMON23800Amsterdam UMC, location AMC12
招募中
4 期
A study to assess the efficacy of tofacitinib for the treatment of chronic pouchitis in adultsChronic pouchitisInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12621000173897Pfizer Australia120
尚未招募
3 期
Comparative Study Between Efficacy of Topical Tofacitinib 2% Ointment and Topical Clobetasol Propionate 0.05% Ointment in Hand Eczema.CTRI/2024/03/064779Acharya Vinoba Bhave Rural Hospital